Analyze Diet
The Veterinary clinics of North America. Equine practice2004; 19(3); 681-695; doi: 10.1016/j.cveq.2003.08.006

Treatment of endotoxemia.

Abstract: Although recognition of clinical signs of endotoxemia is not difficult, determining the underlying cause for the development of endotoxemia may be a challenging task. For this reason, importance must be placed on performance of a thorough physical examination, attention to detail, and determination of whether or not surgical intervention is required. In most instances, a definitive diagnosis may require repeated examinations and laboratory work. In the meantime, affected animals require treatment for endotoxemia, with the aim being to reduce the duration of endotoxemia, prevent the interaction of additional endotoxins with cell surface receptors, and reduce the synthesis and release of inflammatory mediators.
Publication Date: 2004-01-27 PubMed ID: 14740763DOI: 10.1016/j.cveq.2003.08.006Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Review

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research article centers on the treatment of endotoxemia, a severe condition caused by endotoxins in the bloodstream, emphasizing the importance of thorough physical examinations, close attention to details, and the determination for potential surgical intervention.

Identification and Diagnosis

  • The primary challenge in treating endotoxemia is identifying its underlying cause. It is relatively easier to recognize the clinical signs of the disease as they are quite evident; however, pinpointing the root cause requires a highly strategic approach.
  • The initial step towards determining the cause is performing a comprehensive physical examination. This approach does not only involve a superficial inspection but focuses on an in-depth analysis of the symptoms and factors contributing to the onset of endotoxemia.
  • Paying careful attention to subtle symptoms and contextual factors such as diet, environment, and overall health of the animal are essential in this process. The disease could be triggered by various things, meaning that a meticulous, multi-faceted investigation is necessary.
  • Sometimes, despite conducting a comprehensive physical exam and paying close attention to minute details, determining if surgical intervention is needed could be tricky. A careful assessment is needed to finalize whether surgery could be beneficial or further complicate the condition.

Treatment and Management

  • Often, achieving a definitive diagnosis might necessitate multiple examinations and a series of laboratory tests. In such cases, while the diagnostic process is ongoing, the suffering animals must receive prompt treatment for endotoxemia.
  • The overarching goal of the treatment is to minimize the duration and severity of endotoxemia in the affected animal. Due to the critical nature of the condition, effective and rapid treatment methods are crucial for patient survival.
  • Preventing additional endotoxins from interacting with cell surface receptors forms another key objective of the treatment. It is essential to halt the progression of the disease by limiting further contribution of endotoxins to the already harmful condition.
  • Lastly, the treatment aims to reduce the synthesis and release of inflammatory mediators in the body of the affected animal. By addressing this, the excessive immune response that typically accompanies endotoxemia can be kept under control, thereby alleviating the symptoms and improving the prognosis.

Cite This Article

APA
Moore JN, Barton MH. (2004). Treatment of endotoxemia. Vet Clin North Am Equine Pract, 19(3), 681-695. https://doi.org/10.1016/j.cveq.2003.08.006

Publication

ISSN: 0749-0739
NlmUniqueID: 8511904
Country: United States
Language: English
Volume: 19
Issue: 3
Pages: 681-695

Researcher Affiliations

Moore, James N
  • Department of Large Animal Medicine, College of Veterinary Medicine, University of Georgia, Athens, GA 30602, USA. jmoore@vet.uga.edu
Barton, Michelle Henry

    MeSH Terms

    • Animals
    • Anti-Infective Agents / therapeutic use
    • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
    • Endotoxemia / etiology
    • Endotoxemia / therapy
    • Endotoxemia / veterinary
    • Endotoxins / blood
    • Horse Diseases / etiology
    • Horse Diseases / therapy
    • Horses
    • Inflammation Mediators / metabolism
    • Receptors, Cell Surface / metabolism
    • Sepsis / therapy
    • Sepsis / veterinary

    Citations

    This article has been cited 8 times.
    1. Mercer MA, Davis JL, McKenzie HC. The Clinical Pharmacology and Therapeutic Evaluation of Non-Steroidal Anti-Inflammatory Drugs in Adult Horses. Animals (Basel) 2023 May 10;13(10).
      doi: 10.3390/ani13101597pubmed: 37238029google scholar: lookup
    2. Koutsoumanis K, Allende A, Alvarez-Ordóñez A, Bolton D, Bover-Cid S, Chemaly M, Davies R, De Cesare A, Herman L, Hilbert F, Lindqvist R, Nauta M, Ru G, Simmons M, Skandamis P, Suffredini E, Andersson DI, Bampidis V, Bengtsson-Palme J, Bouchard D, Ferran A, Kouba M, López Puente S, López-Alonso M, Nielsen SS, Pechová A, Petkova M, Girault S, Broglia A, Guerra B, Innocenti ML, Liébana E, López-Gálvez G, Manini P, Stella P, Peixe L. Maximum levels of cross-contamination for 24 antimicrobial active substances in non-target feed.u2028Part 9: Polymyxins: colistin. EFSA J 2021 Oct;19(10):e06861.
      doi: 10.2903/j.efsa.2021.6861pubmed: 34729089google scholar: lookup
    3. Shaw SD, Stämpfli H. Diagnosis and Treatment of Undifferentiated and Infectious Acute Diarrhea in the Adult Horse. Vet Clin North Am Equine Pract 2018 Apr;34(1):39-53.
      doi: 10.1016/j.cveq.2017.11.002pubmed: 29426709google scholar: lookup
    4. Chalmeh A, Badiei K, Pourjafar M, Nazifi S. Anti-inflammatory effects of insulin regular and flunixin meglumine on endotoxemia experimentally induced by Escherichia coli serotype O55:B5 in an ovine model. Inflamm Res 2013 Jan;62(1):61-7.
      doi: 10.1007/s00011-012-0551-6pubmed: 22960692google scholar: lookup
    5. Urayama S, Muko R, Muranaka M, Mita H, Ohta M, Matsuda H, Tanaka A. Differential effects of flunixin meglumine and meloxicam on TNF- α production in LPS-stimulated equine neutrophils in vitro. Vet Anim Sci 2025 Dec;30:100513.
      doi: 10.1016/j.vas.2025.100513pubmed: 41078983google scholar: lookup
    6. Uslu M, Corum O, Yazar E. Effect of Meloxicam on the Pharmacokinetics of Cefquinome in Endotoxemic Sheep. Vet Med Sci 2025 Sep;11(5):e70462.
      doi: 10.1002/vms3.70462pubmed: 40905486google scholar: lookup
    7. Zou R, Shi W, Chen M, Zhang M, Wu D, Li H, Zhou H, Li Y, Lu W, Li C, Fan X. Phosphoglycerate mutase 1-mediated dephosphorylation and degradation of Dusp1 disrupt mitochondrial quality control and exacerbate endotoxemia-induced myocardial dysfunction. Theranostics 2024;14(19):7488-7504.
      doi: 10.7150/thno.102647pubmed: 39659576google scholar: lookup
    8. Sousa LN, Winter IC, Varela DD, Luvison EZ, Guzmán JFC, Machado AMV, Figueiredo RDV, Pena GT, Dos Santos ACS, Faleiros RR, Carvalho AM. Lidocaine's Ineffectiveness in Mitigating Lipopolysaccharide-Induced Pain and Peristaltic Effects in Horses. Animals (Basel) 2024 Nov 2;14(21).
      doi: 10.3390/ani14213147pubmed: 39518869google scholar: lookup